Dr Huang is a cancer biologist, genetic engineer and AI entrepreneur. He pioneered the establishment of fast and flexible genetically engineered mouse models using gene silencing and editing technologies, and led the discovery of therapeutic strategies for treating liver cancer and inflammatory bowel disease. He also invented methods to identify disease biomarkers that predict drug responses, and applied machine learning to the study of genes.
Dr Huang is an UNLEASH Sustainable Development Goals Talent and Winner, a Fellow of the 64th Lindau Nobel Laureate Meeting, and recently received a Google Scholarship to attend Singularity University in NASA. He co-founded CLINICAI to early detect cancer.